SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company''s Principal Executive Officer, Brian M. Culley, will present at the BIOCOM Investor Conference on Monday, October 26, 2009, at 10:00 a.m. Pacific time, at the Hyatt Regency in La Jolla, California.
Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web site at http://www.adventrx.com/. An archived presentation will be available on the Web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company''s web site at http://www.adventrx.com/.
ADVENTRX Pharmaceuticals, Inc.
CONTACT: Brian Culley, Principal Executive Officer of ADVENTRX
Pharmaceuticals, +1-858-552-0866; or Investors, Don Markley of
Lippert/Heilshorn & Associates, Inc., +1-310-691-7100, dmarkley@lhai.com, for
ADVENTRX Pharmaceuticals
Web Site: http://www.adventrx.com/
